NASDAQ: BTSGBrightspring Health Services Inc Stock
$16.60-0.21 (-1.25%)
Updated Apr 17, 2025
BTSG Price
$16.60
Fair Value Price
$7.75
Market Cap
$2.90B
52 Week Low
$10.15
52 Week High
$24.82
P/E
-184.44x
P/B
1.76x
P/S
0.29x
PEG
N/A
Dividend Yield
N/A
Revenue
$11.27B
Earnings
-$18.06M
Gross Margin
14.1%
Operating Margin
1.74%
Profit Margin
-0.2%
Debt to Equity
2.59
Operating Cash Flow
$24M
Beta
0.96
Next Earnings
Apr 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
BTSG Overview
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. BrightSpring Health Services, Inc. was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. The company was founded in 1974 and is based in Louisville, Kentucky.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine BTSG's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Health Information Service
Industry Rating
B
BTSG
Ranked#18 of 44
Ranked#18 of 44
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $149.00 | A | |
| $62.37 | A | |
| $1.42 | B |
Be the first to know about important BTSG news, forecast changes, insider trades & much more!
BTSG News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how BTSG scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
BTSG ($16.60) is overvalued by 114.27% relative to our estimate of its Fair Value price of $7.75 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
BTSG ($16.60) is not significantly undervalued (114.27%) relative to our estimate of its Fair Value price of $7.75 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
BTSG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more BTSG due diligence checks available for Premium users.
Valuation
BTSG fair value
Fair Value of BTSG stock based on Discounted Cash Flow (DCF)
Price
$16.60
Fair Value
$7.75
Overvalued by
114.27%
BTSG ($16.60) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
BTSG ($16.60) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
BTSG is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
BTSG price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-184.44x
Industry
11.14x
Market
27.98x
BTSG price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.76x
Industry
3.39x
BTSG is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
BTSG's financial health
Profit margin
Revenue
$3.1B
Net Income
$16.0M
Profit Margin
0.5%
BTSG's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
BTSG's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$5.9B
Liabilities
$4.3B
Debt to equity
2.59
BTSG's short-term assets ($1.89B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BTSG's long-term liabilities ($2.85B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BTSG's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
BTSG's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$90.6M
Investing
-$15.8M
Financing
-$49.6M
BTSG's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
BTSG vs Health Information Service Stocks
Brightspring Health Services Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.